» Articles » PMID: 24710217

The Landscape of Somatic Mutations in Epigenetic Regulators Across 1,000 Paediatric Cancer Genomes

Abstract

Studies of paediatric cancers have shown a high frequency of mutation across epigenetic regulators. Here we sequence 633 genes, encoding the majority of known epigenetic regulatory proteins, in over 1,000 paediatric tumours to define the landscape of somatic mutations in epigenetic regulators in paediatric cancer. Our results demonstrate a marked variation in the frequency of gene mutations across 21 different paediatric cancer subtypes, with the highest frequency of mutations detected in high-grade gliomas, T-lineage acute lymphoblastic leukaemia and medulloblastoma, and a paucity of mutations in low-grade glioma and retinoblastoma. The most frequently mutated genes are H3F3A, PHF6, ATRX, KDM6A, SMARCA4, ASXL2, CREBBP, EZH2, MLL2, USP7, ASXL1, NSD2, SETD2, SMC1A and ZMYM3. We identify novel loss-of-function mutations in the ubiquitin-specific processing protease 7 (USP7) in paediatric leukaemia, which result in decreased deubiquitination activity. Collectively, our results help to define the landscape of mutations in epigenetic regulatory genes in paediatric cancer and yield a valuable new database for investigating the role of epigenetic dysregulations in cancer.

Citing Articles

Discovery of natural products as influenza neuraminidase inhibitors: in silico screening, in vitro validation, and molecular dynamic simulation studies.

Huang B, Lin B, Zheng H, Zheng B, Xue X, Liu M Mol Divers. 2025; .

PMID: 39888540 DOI: 10.1007/s11030-025-11115-8.


Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres.

Freire N, Herlinger A, Vanini J, Dalmolin M, Fernandes M, Nor C Cells. 2025; 14(2).

PMID: 39851500 PMC: 11763699. DOI: 10.3390/cells14020072.


The Role of Chronic Inflammation in Pediatric Cancer.

Mella C, Tsarouhas P, Brockwell M, Ball H Cancers (Basel). 2025; 17(1.

PMID: 39796780 PMC: 11719864. DOI: 10.3390/cancers17010154.


When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock.

Bieuville M, Dujon A, Raven N, Ujvari B, Pujol P, Eslami-S Z Evol Appl. 2024; 17(10):e70024.

PMID: 39444444 PMC: 11496201. DOI: 10.1111/eva.70024.


Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres.

Freire N, Herlinger A, Vanini J, Dalmolin M, Fernandes M, Nor C bioRxiv. 2024; .

PMID: 39386542 PMC: 11463451. DOI: 10.1101/2024.09.23.614476.


References
1.
Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

2.
Neff T, Armstrong S . Recent progress toward epigenetic therapies: the example of mixed lineage leukemia. Blood. 2013; 121(24):4847-53. PMC: 3682337. DOI: 10.1182/blood-2013-02-474833. View

3.
Goo Y, Sohn Y, Kim D, Kim S, Kang M, Kwak E . Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol Cell Biol. 2002; 23(1):140-9. PMC: 140670. DOI: 10.1128/MCB.23.1.140-149.2003. View

4.
Wu G, Broniscer A, McEachron T, Lu C, Paugh B, Becksfort J . Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012; 44(3):251-3. PMC: 3288377. DOI: 10.1038/ng.1102. View

5.
Ramirez J, Hagman J . The Mi-2/NuRD complex: a critical epigenetic regulator of hematopoietic development, differentiation and cancer. Epigenetics. 2009; 4(8):532-6. DOI: 10.4161/epi.4.8.10108. View